Health Care · Services-Offices & Clinics of Doctors of Medicine · NYSE · CIK 1472072 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $4.41Day −4.13%1Y −15.5%Off 52W high −36.8%Vol (1Y) 86.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 4,178 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest0.0% of sh out |
| Days to cover1.0d |
| 13F net flow (QoQ)−0.00% |
| Top-10 13F concentration100.0% |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)CNY 460.5M |
| Earnings (TTM)-CNY 92.8M |
| Net margin−20.2% |
| ROIC−4.2% |
| Sales growth 3Y−1.3% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (CNY). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+14.2% |
| 1Y−15.5% |
| 3Y−68.9% |
| 5Y−85.1% |
| 10Y−89.9% |
| Since incept. (ann.)−13.6% |
Total return through 2026-07-29 · series begins 2009-12-11. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)86.9% |
| Ann. volatility (3Y)163.5% |
| Sharpe (1Y)0.17 |
| Sharpe (3Y)0.37 |
| Max drawdown (1Y)−50.3% |
| Max drawdown (3Y)−83.7% |
| Beta (3Y vs SPY)−1.14 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,723 | $45,016 | 0.01% | new |
| UBS Group AG | 615 | $2,245 | 0.00% | −28.7% |
| MORGAN STANLEY | 100 | $365 | 0.00% | +0.0% |
| SBI Securities Co., Ltd. | 4 | $15 | 0.00% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
No reported quarters on file for CCM.
